ETON SCHEDULE 13G/A: SEC filing

Opaleye Management Inc., Opaleye, L.P., and James Silverman

Filed with the SEC on Nov 6, 2026 · accession 0001493152-26-050455

ETON filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 6, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Opaleye Management Inc., Opaleye, L.P., and James Silverman filed a joint filing agreement as an amendment to their Schedule 13G regarding their beneficial ownership of Eton Pharmaceuticals common stock.

For details, click here →

Key details

FilerOpaleye Management Inc.

FilerOpaleye, L.P.

Subject companyEton Pharmaceuticals, Inc.

President of opaleye management inc. and member of opaleye gp llcJames Silverman

✦ Ask GOAX AI about this filing — what it means for ETON, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ETON?

Click here

Frequently asked questions

What did ETON file with the SEC on Nov 6, 2026?

ETON filed a SCHEDULE 13G/A (SEC filing). Opaleye Management Inc., Opaleye, L.P., and James Silverman filed a joint filing agreement as an amendment to their Schedule 13G regarding their beneficial ownership of Eton Pharmaceuticals common stock.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other ETON SEC filings

Get alerts when ETON files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ETON overview ETON analysis ETON news Latest SEC filings